Intervertebral disc (IVD) degeneration (IVDD) initiates in the nucleus pulposus (NP) and is 25 marked by elevated levels of pro-inflammatory cytokines and matrix-degrading proteases, 26 leading to structural and functional disruption. IVDD therapeutics are currently being 27 investigated; however, such approaches require validation using large animal models that 28 recapitulate clinical, biochemical, and biomechanical hallmarks of the human pathology. Others 29 have previously utilized intradiscal administration of chondroitinase-ABC (C-ABC) to initiate 30 IVDD in the NP of sheep lumbar IVDs. While these studies examined changes in IVD height, 31 hydration, and tissue micro-architecture, changes in biochemical content and mechanical 32 properties were not assessed. Thus, the objective herein was to comprehensively characterize this 33 ovine model IVDD for salient features reported in human degenerate IVDs by evaluating 34 biochemical, biomechanical, and histological changes. Briefly, C-ABC (1U) was administered 35 via intradiscal injection into the L 1/2 , L 2/3 , and L 3/4 IVDs, and degeneration was assessed at 6-and 36 10-weeks via longitudinal magnetic resonance (MR) imaging. After 6 weeks, degenerative 37 samples showed significant reductions in IVD heights (p=0.048) and MR imaging index 38 (p=0.048), which worsened at 10 weeks. Post-mortem degenerate and controls IVDs were 39 evaluated for differences in interleukin-1β concentration, axial and torsional functional spinal 40 unit kinematics, and histological microarchitecture. Degenerate IVDs demonstrated significantly 41 elevated concentrations of interleukin-1β (p=0.002). Additionally, degenerative samples showed 42 increased creep displacement (p=0.022) and compressive stiffness's (p=0.007) concurrent with 43 decreased long-term elastic (p=0.007) and viscous dampening coefficients (p=0.002).
PBS -Fisher Scientific, Hampton, NH) into the L 1/2 , L 2/3 , L 3/4 IVDs (n=9 IVDs) (Fig 1A) . To 141 confirm accurate needle position prior to injection, needle visualization was achieved using 142 lateral and anterior-posterior fluoroscopy (Fig 1B) . The L 4/5 (n=3) and L 5/6 (n=3) IVDs served as 143 vehicle and uninjured controls, respectively. Post-operatively, sheep were monitored until 144 ambulatory, and then returned to standard housing conditions. Following the progression of Semi-quantitative MR image analysis was performed as described by Hoogendoorn et 174 al.
[21] MR imaging index was calculated from T2-weighted images as the product of the cross-175 sectional area and mean signal intensity of the encircled NP using IMPAX 6.6.1.4024 (AGFA 176 HealthCare N.V., Mortsel, Belgium) software. Consistent mid-sagittal IVD imaging was 177 confirmed by ensuring the full cross-sectional of the spinal cord was in view. MR imaging index 178 is expressed as a percentage of week 0 (pre-C-ABC injection) values for normalization. It should 179 be noted that normalization of signal intensity was not performed by comparing to the spinal 180 cord, as has been described by others, because it is a mobile structure with too much Gibbs and 9 181 pulsation artifact. Thus, normalization to normal (week 0) IVDs was deemed most appropriate. (Fig 2A) . Conversely, uninjured IVDs and those 274 injected with vehicle demonstrated no such changes (Fig 2A) . Of note, darkening in adjacent 275 vertebral bodies adjacent to degenerate sheep IVDs were also observed on MR images indicative 276 of endplate abnormalities (Fig 2A) . Normalized MR imaging index of degenerate IVDs was 277 significantly lower at week 6 (65.63±4.01%; p=0.024) and week 10 (57.10%; p=0.023) values.
278
Moreover, these values were significantly lower compared to respective uninjured controls at 279 week 6 (p=0.049) and continued to progress at week 10 (Fig 2B) . No significant changes in MR week 0 values (Fig 2C) . Uninjured and vehicle control IVDs both had average Pfirrmann scores 284 of 1±0 at all time-points investigated. 
294
Normalized DHI values of degenerate IVDs significantly decreased over time, reaching 295 84.91±2.98% (p=0.007) at week 6 and 79.23±0.74% (p<0.001) at week 10 (Fig 2D) . These 296 values were also significantly lower compared to uninjured IVD values at week 6 (94.99±2.00%; 297 p=0.048) and week 10 (99.78±0.61%; p= 0.002), respectively. No significant changes in DHI 298 were observed between uninjured and vehicle control IVDs. 39.7±34.1 [pg/mL]/mg, respectively) (Fig 3) . IL-1β was found to be increased in both the NP-303 and AF-regions of degenerate IVDs compared to uninjured IVDs; however, this was significant 304 (p=0.019) only in the NP (Fig 3) . Kinematic loading (Fig 4A) of FSUs containing degenerate IVDs demonstrated a reduced 312 step displacement (0.11±0.02 mm) and significantly (p=0.022) increased creep displacement 313 (0.50±0.05 mm) compared to FSUs with uninjured IVDs (0.16±0.016 and 0.30±0.02 mm, 314 respectively) (Fig 4C) (Fig 4F) . A similar trend was 330 observed for cyclic compressive stiffness of FSUs containing degenerate IVDs (Fig 4G) . No Macroscopic evaluation of IVDs using the Thompson scale (Fig 5) showed substantial 340 agreement for inter-observer variability (κ grade: 0.75) and showed that the average Thompson 341 grades for degenerate IVDs (3.89±0.20), were significantly greater compared to uninjured 342 (1.00±0.00; p<0.001) and vehicle controls (1.00±0.00; p<0.001), respectively. Semi-quantitative histological scoring showed excellent agreement among observers 347 (ICC: 0.975) and significant differences for uninjured and degenerate scores. (Fig 6) 348 Qualitatively, degenerate IVDs revealed significant alterations and disruption of tissue 349 architecture compared to control IVDs (Figs 6A-F) . Prominent intravertebral herniations were 350 observed in all evaluated degenerate IVDs (Figs 6D-F showed normal, convex AF orientation (Fig 6) . Furthermore, gross morphological changes in 17 356 degenerate IVDs seemed to have pronounced effects on AF structure. Specifically, loss of IVD 357 height seemed to compress AF lamellae while CEP displacement resulted in reduced convexity.
358
Higher magnifications revealed changes in distinct regions of the IVD (Fig 7) . The ability of the 359 CEP and NP to retain stain was severely diminished by C-ABC injection. Additionally, thinning to controls. This was demonstrated by decreases in proteoglycan staining intensity, alterations in 440 lamellar architecture, and the formation of Schmorl nodes, respectively. Taken together, these 441 histomorphological features are suggestive of moderate to severe IVDD. We hypothesize that C-442 ABC degraded NP proteoglycan and the cartilaginous endplates. In fact, cartilaginous endplate 443 thickness was found to be irregular in both macroscopic (i.e. Thompson scoring images) and 444 microscopic analysis. Loss of cartilaginous endplate integrity due to C-ABC treatment could 445 account for the observed formation of Schmorl nodes and the resultant increase in inflammation.
446
The cartilaginous endplate functions to prevent the NP from breaching the vertebral body which 447 prohibits its contact with bone marrow and the immune system. This is critical as NP tissue has 21 448 been shown to be immunogenic when it herniates extradiscally. [52] It is plausible that because 449 sheep lumbar IVDs have been shown to have higher intradiscal pressures compared to human 450 IVDs, [17, 53] in combination with enzymatic disruption of the cartilaginous endplate, most likely 451 resulted in NP tissue breaching into the vertebral body. Such breaches were not observed in 452 vehicle control IVDs which suggests that enzymatic damage to the endplate as opposed to an 453 increase in intradiscal pressure due to injection volume caused the observed Schmorl node differences in spine level. However, data from each IVD was normalized to its respective week 0 471 (baseline) value to account for this.
472

Conclusions
473
In conclusion, we have begun the in-depth characterization of a chemonucleolysis- 
